Key result
Triptans are associated with higher efficacy ratings than ibuprofen for migraine attacks regardless of gender.
Why the study?
The study aimed to analyze citizen science data to examine gender- and migraine type-specific differences in drug effectiveness and pain perception across a large number of individual migraine attacks.
Are there gender- and migraine type-specific differences in drug effectiveness and pain perception during migraine attacks?
Observational (n=1,394)
Are there gender- and migraine type-specific differences in drug effectiveness and pain perception during migraine attacks?
Web-based citizen science data demonstrates significant gender and migraine-type differences in the effectiveness of acute migraine medications like triptans and ibuprofen.
May inform shared decisions on acute migraine therapy; hypothesis-generating for subtype differences and needs prospective validation.
Background: The aim of this work is to analyze reports of migraine attacks collected online in the citizen science project CLUE with respect to gender- and migraine type-specific differences in drug effectiveness and pain perception. Citizen science project data collection opens the possibility to examine these differences based on a large number of individual attacks instead of a simple survey of patients. Methods: One thousand three hundred and ninety four participants reported 47,274 migraine attacks via an online platform and smartphone apps. The reports contained information on the acute medications taken, the evaluation of their effect, and information on pain parameters such as pain intensity, origin, and localization. Chi-square tests were used to investigate whether the effect of acute medications and pain parameters differed when collated by gender and migraine type (migraine with and without aura). Results: Our participants rated the effectiveness of triptans as significantly better than that of ibuprofen. For triptans, significant differences in effectiveness were found when migraine types were distinguished, but no difference was found between genders. For ibuprofen, there were no differences between migraine types but significant differences between gender groups. Examination of pain parameters reveals differences between groups in pain intensity, pain origin, and pain location. The differences are statistically significant, but the effects are small. Conclusions: Despite some methodological limitations, web-based data collection is able to support findings from clinical trials in a real-world setting. Due to the high numbers of participants included and attacks reported, even small differences in medication efficacy and pain parameters between the groups considered can be demonstrated to be statistically significant.
No takes yet. Share an insight, caveat, or question.
Drescher et al. (2021) conducted an observational in Migraine with and without aura (n=1,394). Triptans vs. Ibuprofen was evaluated on Effectiveness of acute medications and pain parameters. Triptans were rated as significantly more effective than ibuprofen for migraine attacks, with triptan efficacy differing by migraine type but not gender.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: